The guest on this week's nationally syndicated Motley Fool Money radio show is Vijay Vaitheeswaran, author of the new book Need, Speed, and Greed: How the New Rules of Innovation Can Transform Businesses, Propel Nations to Greatness, and Tame the World's Most Wicked Problems. In this audio segment, he discusses why major drug companies such as Eli Lilly and Pfizer suffer from having misaligned incentives and how the situation can be remedied.

Chris Hill owns shares of Pfizer. Motley Fool newsletter services have recommended buying shares of Pfizer. The Motley Fool has a disclosure policy. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.